ELAVL1 and cancer: Based on the critical roles of HuR in cancer cells, a variety of methods have been developed to inhibit HuR, including inhibiting HuR/mRNA interaction, HuR dimerization/polymerization, HuR nuclear/cytoplasmic shuttle, and HuR expression (81).